One of the fastest growing consumer segments ever, with an estimated global market size of $146.6B by 2025
10,000 patients in Israel currently on waitlist. Massively underserved domestic market presents significant and immediate opportunity
Israeli government has legalized exports as of January 2019 which is expected to be live early 2020. Positioned to be a premier supplier of medical cannabis to the European Union, one of the biggest patient populations in the world.